Abstract navy and steel-blue geometric pattern representing healthcare real estate platform consolidation
M&A Advisory

Blue Owl Buys Sila Realty for $2.4 Billion: Healthcare Net Lease Joins the Take-Private List

A second major REIT take-private in two weeks signals that healthcare net lease real estate has joined retail and industrial as a target asset class for alternative asset managers.
KAS Advisors • April 23, 2026 7 min read

On April 20, 2026, Sila Realty Trust agreed to be acquired by affiliates of Blue Owl Capital in an all-cash transaction valued at $2.4 billion. The deal pays $30.38 per share, a 19 percent premium to Sila's prior trading close, and follows Ares Management's $1.7 billion take-private of Whitestone REIT just ten days earlier. Two REIT take-privates by alternative asset managers in less than two weeks is no longer a coincidence. It is a market posture, and it has direct implications for owners and operators of healthcare-related real estate.

The Transaction in Brief

Sila Realty Trust is a Tampa-based net lease REIT focused exclusively on healthcare properties. As of March 31, 2026, the company owned 137 real estate properties and three undeveloped land parcels across 65 markets in the United States. The portfolio includes outpatient medical buildings, behavioral health facilities, surgical centers, and other healthcare-adjacent real assets leased to operating tenants on long-duration triple-net leases. The buyer, Blue Owl, manages a real estate platform with significant private capital allocated to net lease and real assets, and the Sila portfolio fits the firm's stated strategy of acquiring scaled, durable cash flow assets in resilient sectors.

The transaction is expected to close in the second or third quarter of 2026, subject to Sila shareholder approval and customary closing conditions. Upon completion, Sila will become a private company and its shares will no longer trade on the New York Stock Exchange.

Why Healthcare Net Lease Specifically

The Ares-Whitestone deal earlier this month centered on grocery-anchored, necessity-retail centers in Sun Belt markets. The Blue Owl-Sila deal centers on healthcare net lease assets across diverse markets and care settings. The two deals address different sectors but share the same logic: alternative asset managers with permanent or semi-permanent capital are buying scaled portfolios of long-lease, recession-resistant real assets that public markets have systematically priced below replacement value.

Healthcare net lease has unique characteristics that make it attractive to private capital. Lease durations tend to be longer than in retail or industrial. The tenants are often regulated entities (hospitals, surgery centers, behavioral health operators) whose business is anchored by demographic demand rather than discretionary consumer spending. The properties themselves are purpose-built and difficult to repurpose, which in real estate logic produces tenant retention and stable cash flow. For an asset manager raising long-duration funds, these are precisely the cash flow characteristics that match the underwriting profile.

The flip side is that the same characteristics that make healthcare real estate attractive to private capital also make it expensive to acquire one property at a time. Aggregating a portfolio of 137 healthcare properties across 65 markets through individual acquisitions would take years and produce execution risk. Acquiring a built portfolio inside a public REIT at a 19 percent premium produces scale immediately.

When private capital is willing to underwrite healthcare real estate at long-duration cap rates and operating-company buyers are valuing the operating business off cash flows alone, leaving the two pools of value bundled is increasingly a planning error rather than a default.
Section divider

What This Means for Healthcare Operators and Owners

The Blue Owl transaction is a public-to-private deal, but the structural lesson applies directly to private healthcare operating companies that own their real estate. A healthcare practice that owns its medical office building, a surgery center that owns its facility, a dialysis platform that owns its clinic locations, and a behavioral health operator that owns its treatment centers are all looking at the same market reality. Private buyers of healthcare real estate are paying meaningful premiums for the right portfolios, and the buyers of healthcare operating companies are increasingly sophisticated about pricing the real estate component separately.

Owners of healthcare operating companies who are five to ten years from a sale should be asking whether the real estate has been positioned as an institutional investment asset. That positioning includes lease structure (length, escalators, triple-net versus modified gross), tenant credit narrative, capital expenditure history, and property condition. A medical office building that has been operated for the convenience of the owner-occupant looks different on diligence than a building that has been operated as an investment asset. The valuation difference can be substantial.

How Deal Teams Are Structuring Healthcare Real Estate Transactions

The most common structure in healthcare operating company sales with real estate exposure is a parallel sale-leaseback. The operating company is sold to a strategic or sponsor buyer who takes the operating entity. The real estate is sold to a separate buyer (typically a sponsor real estate fund or a healthcare-focused REIT) at the same closing. The new operating-company owner becomes the lessee under a long-term net lease negotiated as part of the transaction, and the seller captures both pools of value.

A second structure is a structured leaseback where the operating company buyer acquires the real estate at close and commits to a sale-leaseback within ninety days under a pre-negotiated framework. This structure is more common when the operating company buyer values the optionality of holding the real estate temporarily, or when the lender financing the operating company purchase prefers initial unified ownership.

A third structure relevant in healthcare is the carve-out, where the seller retains the real estate in a separate legal entity prior to close and signs a long-term lease with the new operating company owner. This structure preserves the real estate as a continuing asset for the seller and is often appropriate where the seller wants to remain involved in the practice for a transition period or wants to defer the real estate decision.

The choice among these structures has significant tax, lender, and operational implications. Healthcare real estate often involves regulatory considerations specific to the practice type (Stark Law, anti-kickback rules in physician-owned facilities, Certificate of Need restrictions in some states), and these regulatory considerations interact with the structure choice.

Key Considerations for Healthcare Owners

Forward Look

Three trends are likely to shape healthcare real estate transactions through the rest of 2026. First, alternative asset managers will continue to compete actively for healthcare net lease portfolios, particularly in outpatient settings, behavioral health, and post-acute care, where demographic tailwinds and reimbursement stability support long-duration underwriting. Second, sponsor-led sale-leasebacks of private healthcare operating companies will continue to grow as a deal pattern, especially for owners pursuing partial liquidity without selling the operating business. Third, healthcare-specific REITs and net lease funds will be more aggressive about pre-emptive outreach to private healthcare operators with significant owned real estate footprints.

The structural lesson from two REIT take-privates in two weeks is that real assets in resilient sectors are being repriced upward by private capital while public market multiples lag. Owners of operating companies with embedded real estate are sitting on the same arbitrage.

The Bottom Line

The Blue Owl acquisition of Sila Realty extends the alternative-asset-manager-buys-public-REIT pattern from retail into healthcare, and confirms that scaled healthcare net lease real estate is now a target asset class for private capital. For owners and operators of healthcare-related real estate, the practical implication is that the real estate component of a future sale is increasingly worth treating as an investment asset in its own right, not as a balance sheet adjunct to the operating business. The structural choices made twelve to twenty-four months before a sale (lease structure, tenant narrative, regulatory positioning, ownership entity) determine how much of the real estate value the seller actually captures at closing.

Disclaimer: This article is for informational purposes only and does not constitute financial, investment, tax, or legal advice. KAS Advisors recommends consulting with qualified professionals before making business or financial decisions. Past performance and market trends discussed herein are not indicative of future results.